Results 181 to 190 of about 100,311 (268)

Rare But Specific B‐Cell Receptor Reactivity Against Coxsackievirus A24 in Primary Central Nervous System Lymphomas

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Introduction Primary central nervous system lymphoma (PCNSL) remains a distinct and aggressive malignancy whose underlying antigenic triggers are largely unknown. While autoantigens such as neurabin‐I and SAMD14 have been implicated, the potential role of infectious agents in driving clonal B‐cell receptor selection within the central nervous ...
Igor Age Kos, Onur Cetin, Natalie Fadle, Evi Regitz, Klaus‐Dieter Preuss, Stefan Lohse, Sigrun Smola, Sylvia Hartmann, Falko Fend, Karin Klingel, Florian Scherer, Elisabeth Schorb, Moritz Bewarder, Philipp Staber, Lorenz Thurner   +14 more
wiley   +1 more source

Proteoglycans and Lyme Disease: Molecular Interfaces in Adhesion, Tissue Tropism, and Therapeutic Discovery

Proteoglycan Research, Volume 4, Issue 4, October 2026.
ABSTRACT Lyme disease, caused by spirochetes of the Borrelia burgdorferi sensu lato complex, is a multisystem tick‐borne infection in which bacterial dissemination depends on interactions with host cells and the extracellular matrix (ECM). Proteoglycans (PGs), composed of core proteins modified with glycosaminoglycan (GAG) chains, are abundant and ...
Fuming Zhang, Ke Xia, Yi‐Pin Lin
wiley   +1 more source

Hepatitis B Virus Infection Status in Japanese Children Prior to Universal Vaccination: Sustained Effectiveness of Mother‐to‐Child Transmission Prevention and Residual Infection Burden

Hepatology Research, Volume 56, Issue 10, Page 1457-1465, October 2026.
ABSTRACT Aim To evaluate the effectiveness of prevention of mother‐to‐child transmission (PMTCT) over 25 years, we conducted a nationwide epidemiological survey through a comprehensive assessment of hepatitis B virus (HBV) markers. Methods Two cohorts were recruited before universal vaccination: children aged 9–10 years undergoing school health ...
Aiko Sakai, Yasuhito Tanaka, Hiroshi Yotsuyanagi, Masaya Sugiyama, Ichiro Morioka, Kiyotaka Kosugiyama, Kimiaki Uetake, Tomohiro Katsuta, Atsushi Imamura, Tomoko Takano, Hitoshi Tajiri, Akihito Ishida, Kosuke Ushijima, Yumiko Nakashima, Hiroyuki Moriuchi, Shinji Iwane, Kota Sawada, Yosuke Shimizu, Yukari Uemura, Manabu Tagawa, Masashi Mizokami, Ryo Sumazaki   +21 more
wiley   +1 more source

A scoping review of the acceptability, feasibility and effectiveness of opt‐out blood‐borne virus (BBV) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria

HIV Medicine, Volume 27, Issue 10, Page 1558-1583, October 2026.
Abstract Background Earlier diagnosis of blood‐borne viruses (BBVs)—HIV, hepatitis B (HBV) and hepatitis C (HCV)—remains a significant public‐health focus. Opt‐out testing in secondary healthcare settings can improve early diagnosis and linkage to care as part of BBV transmission elimination targets.
Becky Metcalfe, Karen J. Maxwell, Kirsten Trayner, Max Wilkinson, Sharon Hutchinson, Claudia Estcourt, Alison J. Rodger   +6 more
wiley   +1 more source

Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway

Journal of Viral Hepatitis, Volume 33, Issue 10, October 2026.
ABSTRACT The World Health Organisation aims to eliminate hepatitis C virus (HCV) infection as a public health threat by 2030. We assessed progress towards HCV elimination in Norway until the end of 2024. We used linked national registry data to describe diagnosed cases of HCV infection by treatment uptake and case characteristics, and the incidence of ...
Robert Whittaker, Linda Couëssurel Wüsthoff, Jørgen Eriksson Midtbø, Håvard Midgard, Olav Dalgard   +4 more
wiley   +1 more source

EuroHePP: The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons

Liver International, Volume 46, Issue 10, October 2026.
ABSTRACT People living in prison are disproportionately affected by hepatitis B and C, yet access to prevention, testing, and treatment services remains inconsistent across Europe. Addressing this gap is critical to achieving viral hepatitis elimination targets by 2030.
Serena Fondelli, Guglielmo Arzilli, Filipa Alves da Costa, Christian Brixko, Maria Butí, Joaquin Cabezas, Nicola Cocco, Olivia Dawson, Charlotte Deogan, Gabriele Fischer, Arkadiusz Komorowski, Fadi Meroueh, Linda Montanari, Sara Mazzilli, Éamonn O'Moore, Roberto Ranieri, Rafaela Rigoni, Alessio Saponaro, Carole Seguin‐Devaux, Ehab Salah, Thomas Seyler, Heino Stöver, Lara Tavoschi, Erika Duffell   +23 more
wiley   +1 more source

Investigation of Hepatitis E virus seroprevalence in fattening pigs in Taiwan. [PDF]

Front Vet Sci
Chang CC, Hsiao HP, Chia MY, Chang YC, Liu SW, Yang HY, Chen TH, Huang C, Chang CY.   +8 more
europepmc   +1 more source

Seroprevalence and Factors Associated with <i>Toxoplasma gondii</i> Seropositivity in Small Ruminants in Northeastern Portugal. [PDF]

Animals (Basel)
Pereira T, Rodrigues C, Caldeira MJ, Teixeira Rodrigues F, Jacob-Ferreira J, Lopes AP, Quintas H.   +6 more
europepmc   +1 more source

Serotyping and Seroprevalence Estimation of Pasteurellosis in Ovine and Caprine in Selected Districts of Afar Region, Ethiopia. [PDF]

Vet Med Sci
Dubie T, Abera B, Hamid M, Molla T, Fentahun G, Yihunie FB, Negash W, Mohammed S, Desalegn B.   +8 more
europepmc   +1 more source

Seroprevalence of hepatitis E in blood donors in Santiago, Chile: a monocentric cross-sectional study. [PDF]

IJID Reg
Porte L, Weitzel IB, Martínez-Valdebenito C, Pizarro G, Bustamante V, Weitzel T.   +5 more
europepmc   +1 more source